BRCA2 and breast cancer: Several missense variants of uncertain significance (VUS) identified in BRCA2 in breast cancer patients are located in the N-terminal region predicted to be phosphorylated by PLK1 (around S193) (Breast information core (BIC)26 and BRCAShare27), summarized in Supplementary Table 1.